Competitive Intelligence in Pharma USA | April 13-14, 2010

3rd AnnualVIBpharmaTuesday 13 – Wednesday 14 April 2010, Philadelphia, PA, USAImplementing an eff ective and cohesive competitive intelligence strategy in your business3 KEy HIGHlIGHTS INClUDE:KEy INDUSTRy SPEAKERS INClUDE:• Hear industry case studies for implementing Debbie Allison, Bonnie Hohof, Director a company wide approach to competitive Senior Director, CI, of CI Information and intel igence MERCKResearch, SCIP• Meet over 13 Biotech and Pharma Mona Gupta, Brian Moss,Manufacturers and discover their cutting edge CI Manager, Senior Director, approaches to CIElI lIlly & COMPANyMarket Research, • Network with leading consultancies to assist Manish Maheshwari, SHIREyou in maximizing the ROI of your CI processesManager Business Arthur Vermillion, Intelligence Services, Executive Director, CI, GSKPPDThursday, April 15, 2010Sue Ward, Don't miss the post conference workshop led by Fuld Director, CI, & Company focusing on intergrating competitive intelligence and war gaming into brand team and R&D PFIzERdecision making.Marjorie Norman, Don’t misA MUST ATTEND WORKSHOP FOR CI PROFESSIONALSDirector Global CI s out on this imporand Knowledge tnetwant orkManagement, ing evSilver Sponsors:ent! PFIzERMeet with seniorl evel CI peersto discuss the latest industry challengesRegister online now at: www.ciinpharma-events.com/usa2010 Program Day One Tuesday 13 April 201008:30 Coffee and Registration2:00 Uncovering the latest innovations, strategy and best practice to maximize the benefits of CI 08:50 Opening remarks from the Chair ●Enhancing business decision-making and organizational performance through the skilled application of intelligenceMaximizing the benefits of CI with cutting ●Learning from other industries – advanced CI strategies for a competitive environment edge strategies ●Adapting the intelligence process to the changing business world 09:00 Opening Keynote Session: Evaluating the changing Mona Gupta, CI Manager, ElI lIllyrole of the CI professional – Ensuring you have the Streamlining internal CI processes for extensive competitive edge by fully understanding the evolving business requirements of competitive intelligenceinformation collection and knowledge sharing● Highlighting cutting edge methodologies2:40 Implementing CI as a global initiative and ● Uncovering alternative approaches to CI strategy and deciding what’s right for youmaintaining consistent communication of ● Investigating opportunities to outsource and utilise external information from all locations to those that need it ●resources to increase the efficiency of your operation Developing a strategy for the execution of a CI function across ● Ensuring employee best practice for optimum reporting and multiple sites and locations●results Facilitating a communication and reporting process for the ● Forecasting and planning strategic operations in a highly efficient transfer of information●changeable environment Debating the differing strategies of local and global CI Debbie Allison, Senior Director, CI, MERCKapproaches● Ensuring the rapid transfer of information for early warning 09:40 Keynote Session: Unlocking the competitive intelligence alerts● Integrating local CI information into your global database and potential of social networks and social mediamaking accessible throughout the organization ●Describing the current social networking landscape and how Marjorie Norman, Director Global CI and Knowledge patterns of communication are changing Management, PFIzER ●Presenting examples of social networking in practice using examples from within and outside the pharmaceutical industry ●Analyzing how these evolving social networks can be accessed and 3:20 Afternoon refreshments and networkingapplied in a competitive intelligence context ●Assessing how to overcome potential intelligence “red herrings” 3:50 Maximizing the strategic benefits by ensuring CI is ●Exploring implications for the pharmaceutical competitive integrated into the daily processes of the businessintelligence professional ●Creating data collection and information sharing processes to Anthony Nagle, Managing Director, Fuld & Co optimize the use of information ●Integrating CI into daily operations to ensure a continuous 10:20 Measuring the ROI of CI activities to ensure a targeted approach to knowledge acquisitionand successful campaign ●Ensuring collected information is effectively used and analyzed by ●Evaluating the variety of tools and techniques for measuring ROI strategic planning departments ●Understanding which activities must be measured and how ●Defining the most efficient internal marketing strategies for CI and ●Ensuring information is reported and recorded accurately for alternative promotional toolsexacting analysis and continuous improvementBonnie Hohof, Director of CI Information and Research, SCIP ●Using past experience and reports to build a successful campaignManish Maheshwari, Manager Business Intelligence Services, GSK4:30 Case Study: Structuring internal CI processes to ensure easy communication and optimum knowledge 11:00 Refreshments and networkingsharing ● Implementing companywide communication systems for efficient data sharingOptimizing the ROI of CI with enhanced ●Building in house communications systems and databases for communicationlong term CI strategies11:30 Panel Session: Meeting the internal customers of CI ●Reviewing best practice strategies for maximum distribution and During this panel session, VIBPhama will uniquely bring together utilization of competitor informationa panel of key customers of competitive intelligence, including ● Identifying limitations within your CI processes and taking steps marketing, business development and commercial strategy. The to repair themobjective of this session is to better understand the applications of Brian Moss, Senior Director, Market Research, SHIRECI analysis in order to improve efficiency, pinpoint information to target and adopt a more strategic approach5:10 Chairs closing remarks and end of day oneTo be joined by a selection of speakers from the day12:15 Ensuring employee engagement and buy in across the company for a 360˚ approach to CI and reporting ●Utilizing a centralized reporting system to achieve effective knowledge sharingDo you wish to exhibit your products ●Evaluating strategies to ensure buy-in from all staff on both the execution of CI activities but also of ethical approachesand services at this exclusive event? ●Implementing a global staff training program to maximize CI potentialIf you want to be a part of this successful ●Building a communication chain to ensure information is reported event, we have a number of sponsorship and gets to the right people for maximum benefit opportunities available. Sue Ward, Director, CI, PFIzERContact Paul Adams on +44 (0)207 753 4259 or 12:55 Lunch and networkingby email at pauladams@arena-international.com Program Day Two Wednesday 14 April 201008:30 Registration12:45 Lunch and networking09:00 Opening remarks from the Chair1:45 Best Practice for CI – developing operational Optimizing CI processes in a changing environmentguidelines for effi cient and risk free operations ●Utilizing policies and guidelines to mitigate fi nancial and corporate 09:15 Keynote Session: Highlighting the threats and risk pinpointing the opportunities of Generics and ●Developing a balanced operational code of conduct that guide and protect employees and strategiesBiosimilars ●Ensuring the success of your CI eff orts with decentralized functions ● Exploring developments in the biosimilar and generics industry to that increase effi ciency understand the potential impact on your businessElsa Pan, Manager Strategic Analysis & Intelligence,● Understanding the role of CI in mitigating the risks presented by BRISTOl MyERS SQUIBBgenerics and biosimilars● Assessing the value of investment in CI of expiring patents to maintain a strong market share2:25 Implementing eff ective counter intelligence ● Predicting the growth of the generics and biosimilars industry and strategies to safeguard your valuable data from CI its eff ect on the future of the industrymissions by your competitorsArthur Vermillion, Executive Director, CI, PPD ●Revealing methodologies to protect your information from competitor CI eff orts10:00 Case Study: Adapting a Competitive Intelligence ●Maximizing corporate information security eff ortsoperation in the face of mergers and acquisitions ●Evaluating strategies to minimize vulnerability and mitigate risks● Understanding the full impact of mergers and acquisitions on CI ●Highlighting the latest strategies, technologies and trends in and counter intelligences functionscounter intelligence to protect your company against future threats● Adapting and rebuilding a CI team within a merging teamRobert lieberman, Associate Director, Global Market Research, ● Identifying and repairing weaknesses in a combined team BAyER● Standardizing information collection across the entire organization and integrating a cohesive CI approach3:05 Refreshments and networkingDeborah Dauber, Associate Director, CI, GENETECH3:30 legal and ethical best practice – ensuring you are 10:40 Refreshments and networkingachieving maximum results whilst remaining on the right side of legislation with ease11:10 Evaluating the key ingredients to ensuring eff ective ●Ensuring a complete understanding of the current legal and ethical Competitive Intelligenceframework● A New Paradigm for portfolio decision support by integrating ●Maintaining reputation and corporate image with a clean cut • Market Assessmentsapproach and damage limitation• Drug Pipeline Analysis ●Discussing strategies and approaches for eff ective information • Eff ective Clinical Trial Analysis collection whilst remaining within legal and ethical boundaries• Thorough Competitive Intelligence ●Highlighting legal developments to ensure you are up to date with • Intellectual Property, deals and newsall legislation and can operate without doubt• Supports multiple stake holders Susanne laningham, Director Business Information, AMGEN● Optimal resource - on shore/off shore hybrid model lDr. Vimal Mehta, Chairman, BIO-X-CEl4:10 Chairs closing remarks11:50 Panel Session: Uncovering CI in emerging markets – 4:20 Close of conferencediscussing the part they have to play and strategies for carrying out CI missions in these markets to maintain a competitive edge ●An overview of the development of emerging markets and their own CI strategiesRegi s●Discussing the cultural diff erences that must be taken into account in ter for order to conduct eff ective CIthis ye a●Evaluating alternative approaches to conducting CI in emerging r's posmarketst confer ●Predicting global market changes to develop emerging market CI ence strategiesworkshop fr ●Utilizing CI to maximize your opportunities for global growthomRamesh Arjunji, Director Commercial Analytics, FENDO PHARMACEUTICAlSuld & Carole Robinson, Executive Director, PBRIGCompanMichelle Talin, CI Senior Manager, MEDIMMUNEyREGISTER ONLINE NOW! Web: www.ciinpharma-events.com/usa2010Email: book@arena-international.com Tel: +44 (0) 207 753 4268 Fax: +44 (0) 207 915 9773Sponsors and Media Partners Post-conference workshopSilver sponsorsLinking competitive intel igence Fuld & Co, the global leader in competitive intelligence, delivers (and war gaming) into brand team customised research and analysis on markets, competitors, suppliers, and customers. Our findings and and R&D decision makingrecommendations enable clients to make informed judgments related to new product introductions, life-cycle management initiatives, Thursday 15th April 2010restructuring, organisational bench marking and a variety of other critical business decisions. www.fuld.comLed by: Arjan Singh, Vice President, FULD & COMPANYAbout the workshop:BioXcel offers business analytics and intellectual property services to healthcare This workshop is for those with CI responsibilities in the sectors and related industries worldwide. pharmaceutical and biotech industry who want to learn more Its unique, Hybrid Global Delivery Model consists of US-based, executive management and highly flexible analytics teams in India about improving the integration of intelligence into brand team (MS, MTech, PhDs, MDs, Patent Agents, MBAs) providing high quality, decision making. The agenda will be a mixture of presentation integrated services in competitive intelligence. www.bioxcel.comand facilitated discussion to discuss amongst other topics; how to fuel the competitive intelligence cycle with inputs that are both Exhibitors relevant and timely to your target audience as well as providing practical examples of how others have embedded competitive intelligence into the strategic decision making process. At the end of the workshop Arjan Singh will share his thoughts on how to manage the continually evolving the CI cycle and the building of processes that work to sustain the integration of CI into the Media Partnersdecision making process.Pharmaceutical Technology is used daily as a means of creating partnerships and as a point of reference by professionals Workshop agenda:within the pharmaceutical industry. This comprehensive resource supplies the latest news releases, detailed 1:00 Delegate registration and coffeeinformation on industry projects, white papers, event information and a thorough breakdown of products and services. 1:30 Session 1: Moving from 'interesting' www.pharmaceutical-technology.comintelligence to actionable intelligence – what is actionable?Drug Development Technology ●Discussing the key differences between ‘interesting’ and is a procurement and reference resource 'actionable' intelligence providing a one-stop-shop for professionals ●The best intelligence is worthless if it doesn’t promote and decision makers within the drug any action development and medicines industry. We provide a comprehensive breakdown of drug development contractors and suppliers, up-to-date 2:00 Session 2: The compound life cycle and CI news and press releases, white papers and detailed information on ●Discussing the stages of a compound and exploring what current industry projects and trends. Our recruitment area provides career these changing issues are and how to use them to fuel the information and the latest job vacancies in the field. CI efforts to assist decision www.drugdevelopment-technology.com2:30 Afternoon coffee break Pharmaceutical Business Review is the world's leading pharma website, being used by over 3:00 Session 3: CI integration - lessons learned and 100,000 visitors every month. For further common pitfallsinformation contact jsharp@industryreview.com ●Practical examples of how others have embedded competitive intelligence into the decision making process World Pharmaceutical Frontiers The through understanding corporate culture and linking CI to World Pharmaceutical Frontierswww.worldpharmaceuticals.netpharmaceutical industry is changing fast. how decisions are actually made inside the organisation There are more regulations, technologies, faster product launches and shorter product life cycles than ever before. 3:30 Session 4: Developing a world class CI World Pharmaceuticals frontiers is, and will continue to be, at the forefront capability - a model for developmentof these changes, so visit us at www.worldpharmaceuticals.net and stay up to date with all latest developments ●A proprietary model for development of CI ●Discussing the stages of developing a world class CI capability PMR Publications provides reliable market ●The practical steps to sustain the integration of intel igence intelligence for business professionals interested into decision makingin Central and Eastern European countries. Publications by PMR analyse the business climate in the region, in 4:00 Session 5: Questions and answersparticular in the construction, retail, IT, telecommunications and pharmaceutical sectors. PMR Publications offers both free and paid 4:30 Afternoon coffee break subscription newsletters, internet news portals and in-depth reports. www.pmrpublications.comPharmaVOICE magazine and its supporting VIEW About the workshop leader:publications, provide commentary about the Arjan Singh is Vice President of Fuld & Company’s Consulting challenges and trends impacting the life-sciencesindustry, covering a range of issues from molecule through market. Practice. He has over eleven years experience as a CI practitioner, PharmaVOICE's more than 17,500 U.S.-based subscribers are also creating intelligence processes for numerous Fortune 500 kept abreast of the latest trends through additional media resources, companies (including various biotech and pharmaceutical including WebSeminars, Podcasts, Videocasts, and White Papers. companies). He has trained over 1000 people in the concepts www.pharmavoice.comof CI at various venues including the Academy of Competitive Intelligence (ACI), Society of Competitive Intelligence Professionals (SCIP) and in specific in-house sessions for clients.BOOKING FORM Competitive Intelligence in Pharma USATuesday 13 – Wednesday 14 April 2010, Philadelphia, USAPrices & Payment Information (please tick option)Five Easy Ways To Book: Yes, I would like to register for the event:Book beforeBook beforeBook after02.13.201003.15.201003.15.2010■ Register online at Representatives from pharma and biotech companies www.ciinpharma-events.com/register.aspI would like the VIP attendees package to include the two day conference + interactive CD-ROM + post conference $2949 $3049 $3199■ Email us atworkshop for Pharma and Biotech representatives events@arena-international.comI would like to attend the two day conference only $1499 $1599 $1749■ Tel +44 (0)20 7753 4268I would like to attend the post conference workshop only■ Fax +44 (0)20 7915 9773 $900 $1000 $1150■ PostI would like to attend the two day conference + post Arena International Events Groupconference workshop $2399 $2499 $2649John Carpenter HouseFees for Solution providersJohn Carpenter Street I would like the VIP attendees package to include the two london, EC4y 0AN, UKday conference + interactive CD-ROM for Solution Providers $3599 $3699 $3849I would like to attend the two day conference only $2999 $3099 $3249Total All AttendeesDiscount code if applicable ______________I can’t attend the conference but would like to receive an $650 $650 $850Discounts are at the discretion of Arena interactive CD-ROMInternational and are not cumulativeVenue DetailsThe three day conference will take place on the 13-14 April 2010. The venue for the three days will be held at a centrally located hotel in Philadelphia, PA, USA. For further information contact our Operations department on +44 (o) 207 753 4201.Are you registered?You will always receive an acknowledgement of your booking. If you do not receive anything, please call us on +44 (0) 20 7753 4268 to make sure we have received your booking.All total fees are subject to a 2.5% service chargeArena International Conference Delegate terms and conditions5 General: You, your executive/s or your agents may not transfer or assign any of the rights or obligations of this 1 Scope of Agreement: These are the conditions of the contract between you, the Client (“You” and “your”) and Agreement (in whole or part) without our prior consent. Any attempt to resell, assign or transfer rights without our Arena International Events Group (“Arena International Events Group”, “we”, “us” and “our”) governing your use of our consent will entitle us to cancel the contract without liability to you.services, including the conference registration as set out in your booking form. This agreement constitutes the entire • This agreement is governed by and will be construed in accordance with English law and each party irrevocably agreement between Arena International Events Group and you. All prior agreements understandings and negotiations agrees that the courts of England will have the non-exclusive jurisdiction to deal with any disputes arising out of or in and representations (save for fraudulent misrepresentation) whether oral or in writing are cancelled in their entirety. The connection with this agreement.terms of any other electronic communications will not form part of this agreement.• Grant of Licence: If your booking includes the CD-ROM, you warrant that you will only use the CD-ROM for 2 Our commitment to you: Should the Event be cancelled or the location be changed for reasons or circumstances your business purposes and shall not, without our prior written consent, make available, copy, reproduce, transmit, beyond our control, we reserve the right to reschedule the Event, including changing the location, upon written disseminate, sell, licence, distribute, publish, broadcast or otherwise circulate the CD-ROM (or any part of it) to any notice to you. Should the event fail to be rescheduled for any reason your refund shall not exceed the total charge other person other than in accordance with these terms and conditions.received by us from you.• Arena International Events Group is subject to the UK Data Protection Act 1998 and is registered in the UK with the 3 Payment Terms: The Total Fees specifi ed on the booking form are subject to an additional service charge of 2.5% Information Commissioner to process your personal information. Our primary goal in collecting personal information (“Service Charge”) applied to cover administration costs, and are exclusive of VAT and any other applicable sales tax from you is to give you an enjoyable customised experience whilst allowing us to provide services and features that which shall be payable in addition.most likely meet your needs. We collect certain personal information from you, which you give to us when using our • Following completion and return of the booking form, full payment including Service Charge is required within Sites and/or registering or subscribing for our products and services. We also collect certain personal data from other fi ve days from the invoice date or prior to the event if this is sooner. All registrants must provide a credit card number group companies to whom you have given information through their websites. If you do not want us to continue using as a guarantee at the time of booking. We reserve the right to charge your card in full if payment is not received in this information please notify us at unsubscribe@arena-international.com. Any personal information supplied to SPG accordance with these payment terms. We reserve the right to refuse admission if full payment is not received in Media Ltd as part of this registration process and/or any other interaction with SPG Media Ltd will be collected, stored accordance with these terms.and used by SPG Media Ltd its subsidiaries, related companies or affi liates in accordance with the SPG Media Ltd 4 Cancellations: In the event of cancellation, 100% of the event fee is payable and non-refundable. All cancellation Privacy Policy. Please email privacypolicy@arena-international.com for a copy of the SPG Media Ltd Privacy Policy.requests must be submitted to us in writing. If we agree to your cancellation then all cancellation fees are payable • The working language of the Event is English. Executives requiring an interpretation service must make their own immediately after the acceptance of your cancellation in writing by us.arrangements at their own expense.Arena International Events Group, a trading division of SPG Media Ltd. Registered Offi ce: 55 North Wharf Road, London, W2 1LA, UK. Registered in England No. 01155599. www.arena-international.comDelegate Details please photocopy form for multiple bookingsMr/Mrs/Ms/Dr: First Name: Surname: Email: Tel: Job Title: Fax: Department:Company DetailsCompany: Address:Town: Postcode: Country:VAT Number: Nature of Business:Payment DetailsPurchase Order No.■ I enclose a cheque drawn on a UK bank (please make cheque payable to SPG Media Ltd and write reference CIP0410 on the reverse)■ I will transfer payment to your Lloyds TSB account City Branch, London, UK: 01492549, sort code 30-00-02 (using reference CIP0410)■ I would like to pay with my credit card ■ Visa ■ Mastercard ■ AMEX ■ Maestro ■ SoloCard Number: Expiry Date: Issue Date: CSV*: Cardholder's Name: Cardholder's Address: *The CSV number is the last 3 digit number on the reverse of the card ■ Yes, I have read and understood the terms and cancellations conditions and am happy to proceed with my registration MK1Signature Date